Risks and Responsibilities in Prescribing Opioids for Chronic Noncancer Pain, Part 2: Best Practices

References

• . Chou R, Qaseem A, Snow V,. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007;147(7):478–491
   PubMed Web of Science ®Google Scholar
• . Zhang W, Moskowitz RW, Nuki G,. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16(2):137–162
   PubMed Web of Science ®Google Scholar
• . Manchikanti L, Abdi S, Atluri S,. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2—guidance. Pain Physician. 2012;15( 3 suppl):S67–S116
   PubMed Web of Science ®Google Scholar
• . Bohnert AS, Valenstein M, Bair MJ,. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305(13):1315–1321
   PubMed Web of Science ®Google Scholar
• . US Department of Health and Human Services. Results from the 2011 National Survey on Drug Use and Health: Mental Health Findings. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. http://www.samhsa.gov/data/NSDUH/2k11MH_FindingsandDetTables/2K11MHFR/NSDUHmhfr2011.pdf. Accessed June 10, 2013
   Google Scholar
• . Morley-Forster PK, Clark AJ, Speechley M, Moulin DE. Attitudes toward opioid use for chronic pain: a Canadian physician survey. Pain Res Manag. 2003;8(4):189–194
   PubMedGoogle Scholar
• . Bhamb B, Brown D, Hariharan J, Anderson J, Balousek S, Fleming MF. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin. 2006;22(9):1859–1865
   PubMed Web of Science ®Google Scholar
• . Spitz A, Moore AA, Papaleontiou M, Granieri E, Turner BJ, Reid MC. Primary care providers' perspective on prescribing opioids to older adults with chronic non-cancer pain: a qualitative study. BMC Geriatr. 2011;11:35
   PubMed Web of Science ®Google Scholar
• . Upshur CC, Luckmann RS, Savageau JA. Primary care provider concerns about management of chronic pain in community clinic populations. J Gen Intern Med. 2006;21(6):652–655
   PubMed Web of Science ®Google Scholar
• . Gordon A. The five pillars of pain management. Pain Manag. 2012;2(4):335–344
   PubMedGoogle Scholar
• . Argoff C, Kahan M, Sellers E. Preventing and managing aberrant drug-related behavior in primary care: systematic review of outcomes evidence. J Opioid Manag. 2014;10(2):119–134
   PubMedGoogle Scholar
• . Vijayaraghavan M, Penko J, Guzman D, Miaskowski C, Kushel MB. Primary care providers' views on chronic pain management among high-risk patients in safety net settings. Pain Med. 2012;13(9): 1141–1148
   PubMed Web of Science ®Google Scholar
• . Reisfield GM, Webb FJ, Bertholf RL, Sloan PA, Wilson GR. Family physicians' proficiency in urine drug test interpretation. J Opioid Manag. 2007;3(6):333–337
   PubMedGoogle Scholar
• . Reisfield GM, Bertholf R, Barkin RL, Webb F, Wilson G. Urine drug test interpretation: what do physicians know? J Opioid Manag. 2007;3(2):80–86
   PubMedGoogle Scholar
• . Levy S, Harris SK, Sherritt L, Angulo M, Knight JR. Drug testing of adolescents in ambulatory medicine: physician practices and knowledge. Arch Pediatr Adolesc Med. 2006;160(2):146–150
   PubMedGoogle Scholar
• . Starrels JL, Fox AD, Kunins HV, Cunningham CO. They don't know what they don't know: internal medicine residents' knowledge and confidence in urine drug test interpretation for patients with chronic pain. J Gen Intern Med. 2012;27(11):1521–1527
   PubMed Web of Science ®Google Scholar
• . Reisfield GM, Goldberger BA, Bertholf RL. “False-positive” and “false-negative” test results in clinical urine drug testing. Bioanalysis. 2009;1(5):937–952
   PubMed Web of Science ®Google Scholar
• . Von Seggern RL, Fitzgerald CP, Adelman LC, Adelman JU. Laboratory monitoring of OxyContin (oxycodone): clinical pitfalls. Headache. 2004;44(1):44–47
   PubMedGoogle Scholar
• . Canadian guideline for safe and effective use of opioids for chronic non-cancer pain. National Opioid Use Guideline Group (NOUGG). http://nationalpaincentre.mcmaster.ca/opioid/. Accessed September 18, 2013
   Google Scholar
• . Chou R, Fanciullo GJ, Fine PG,. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113–130
   PubMed Web of Science ®Google Scholar
• . Brown J, Setnik B, Lee K,. Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting. J Opioid Manag. 2011;7(6):467–483
   PubMedGoogle Scholar
• . Pergolizzi JV Jr, Gharibo C, Passik S,. Dynamic risk factors in the misuse of opioid analgesics. J Psychosom Res. 2012;72(6):443–451
   PubMed Web of Science ®Google Scholar
• . Starrels JL, Becker WC, Weiner MG, Li X, Heo M, Turner BJ. Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. J Gen Intern Med. 2011;26(9):958–964
   PubMed Web of Science ®Google Scholar
• . Kahan M, Mailis-Gagnon A, Wilson L, Srivastava A. Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population. Can Fam Physician. 2011;57(11):1257–1266, e1407–e1418
   PubMed Web of Science ®Google Scholar
• . Gourlay DL, Heit HA. Universal precautions revisited: managing the inherited pain patient. Pain Med. 2009;10( Suppl 2):S115–S123
   PubMed Web of Science ®Google Scholar
• . Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6(6):432–442
   PubMed Web of Science ®Google Scholar
• . Butler SF, Budman SH, Fernandez KC,. Development and validation of the Current Opioid Misuse Measure. Pain. 2007; 130(1–2):144–156
   PubMed Web of Science ®Google Scholar
• . Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN. Validation of the revised Screener and Opioid Assessment for Patients With Pain (SOAPP-R). J Pain. 2008;9(4):360–372
   PubMed Web of Science ®Google Scholar
• . Compton PA, Wu SM, Schieffer B, Pham Q, Naliboff BD. Introduction of a self-report version of the Prescription Drug Use Questionnaire and relationship to medication agreement noncompliance. J Pain Symptom Manage. 2008;36(4):383–395
   PubMed Web of Science ®Google Scholar
• . Cicero TJ, Lynskey M, Todorov A, Inciardi JA, Surratt HL. Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse. Pain. 2008;139(1):127–135
   PubMed Web of Science ®Google Scholar
• . Green TC, Grimes Serrano JM, Licari A, Budman SH, Butler SF. Women who abuse prescription opioids: findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database. Drug Alcohol Depend. 2009;103(1–2):65–73
   PubMed Web of Science ®Google Scholar
• . Hartzler B, Donovan DM, Huang Z. Comparison of opiate-primary treatment seekers with and without alcohol use disorder. J Subst Abuse Treat. 2010;39(2):114–123
   PubMed Web of Science ®Google Scholar
• . Morasco BJ, Dobscha SK. Prescription medication misuse and substance use disorder in VA primary care patients with chronic pain. Gen Hosp Psychiatry. 2008;30(2):93–99
   PubMed Web of Science ®Google Scholar
• . Barth KS, Becker WC, Wiedemer NL,. Association between urine drug test results and treatment outcome in high-risk chronic pain patients on opioids. J Addict Med. 2010;4(3):167–173
   PubMed Web of Science ®Google Scholar
• . Cohen P, Chen H, Crawford TN, Brook JS, Gordon K. Personality disorders in early adolescence and the development of later substance use disorders in the general population. Drug Alcohol Depend. 2007;88( Suppl 1):S71–S84
   PubMed Web of Science ®Google Scholar
• . Savage SR, Kirsh KL, Passik SD. Challenges in using opioids to treat pain in persons with substance use disorders. Addict Sci Clin Pract. 2008;4(2):4–25
   PubMedGoogle Scholar
• . Fenton MC, Keyes K, Geier T,. Psychiatric comorbidity and the persistence of drug use disorders in the United States. Addiction. 2012;107(3):599–609
   PubMed Web of Science ®Google Scholar
• . Seal KH, Shi Y, Cohen G,. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012;307(9):940–947
   PubMed Web of Science ®Google Scholar
• . Conroy E, Degenhardt L, Mattick RP, Nelson EC. Child maltreatment as a risk factor for opioid dependence: Comparison of family characteristics and type and severity of child maltreatment with a matched control group. Child Abuse Negl. 2009;33(6):343–352
   PubMed Web of Science ®Google Scholar
• . Castro M, Kraychete D, Daltro C, Lopes J, Menezes R, Oliveira I. Comorbid anxiety and depression disorders in patients with chronic pain. Arq Neuropsiquiatr. 2009;67(4):982–985
   PubMed Web of Science ®Google Scholar
• . Gupta A, Patton C, Diskina D, Cheatle M. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors. Pain Physician. 2011;14(4):383–389
   PubMed Web of Science ®Google Scholar
• . Becker N, Sjogren P, Bech P, Olsen AK, Eriksen J. Treatment outcome of chronic non-malignant pain patients managed in a Danish multidisciplinary pain centre compared to general practice: a randomised controlled trial. Pain. 2000;84(2–3):203–211
   PubMed Web of Science ®Google Scholar
• . Kidner CL, Mayer TG, Gatchel RJ. Higher opioid doses predict poorer functional outcome in patients with chronic disabling occupational musculoskeletal disorders. J Bone Joint Surg Am. 2009;91(4):919–927
   PubMedGoogle Scholar
• . Townsend CO, Kerkvliet JL, Bruce BK,. A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: comparison of treatment outcomes based on opioid use status at admission. Pain. 2008;140(1):177–189
   PubMed Web of Science ®Google Scholar
• . Dunn KM, Saunders KW, Rutter CM,. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152(2):85–92
   PubMed Web of Science ®Google Scholar
• . Franklin GM, Mai J, Turner J, Sullivan M, Wickizer T, Fulton-Kehoe D. Bending the prescription opioid dosing and mortality curves: impact of the Washington State opioid dosing guideline. Am J Ind Med. 2012;55(4):325–331
   PubMed Web of Science ®Google Scholar
• . Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;171(7):686–691
   PubMed Web of Science ®Google Scholar
• . Romach MK, Schoedel KA, Sellers EM. Update on tamper-resistant drug formulations. Drug Alcohol Depend. 2013;130(1–3):13–23
   PubMed Web of Science ®Google Scholar
• . Cicero TJ, Ellis MS, Surratt HL. Effect of abuse-deterrent formulation of OxyContin. N Engl J Med. 2012;367(2):187–189
   PubMed Web of Science ®Google Scholar
• . Butler SF, Cassidy TA, Chilcoat H,. Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment. J Pain. 2013;14(4):351–358
   PubMed Web of Science ®Google Scholar
• . Cassidy TA, McNaughton EC, Lobo K, Budman SH, Butler SF. Abuse of reformulated OPANA® ER: early findings from NAVIPPRO® data streams. Presented at: American Society of Addiction Medicine 44th Annual Medical-Scientific Conference, April 25–28, 2013, Chicago
   Google Scholar
• . Kahan M, Srivastava A, Wilson L, Gourlay D, Midmer D. Misuse of and dependence on opioids: study of chronic pain patients. Can Fam Physician. 2006;52(9):1081–1087
   PubMedGoogle Scholar
• . Passik SD, Kirsh KL, Whitcomb L, Dickerson PK, Theobald DE. Pain clinicians' rankings of aberrant drug-taking behaviors. J Pain Palliat Care Pharmacother. 2002;16(4):39–49
   PubMedGoogle Scholar
• . Cone EJ, Caplan YH. Urine toxicology testing in chronic pain management. Postgrad Med. 2009;121(4):91–102
   PubMed Web of Science ®Google Scholar
• . Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009;10(2):131–146
   PubMed Web of Science ®Google Scholar
• . Fishbain DA, Cutler RB, Rosomoff HL, Rosomoff RS. Validity of self-reported drug use in chronic pain patients. Clin J Pain. 1999;15(3):184–191
   PubMed Web of Science ®Google Scholar
• . Denis C, Fatseas M, Beltran V,. Validity of the self-reported drug use section of the Addiction Severity Index and associated factors used under naturalistic conditions. Subst Use Misuse. 2012;47(4):356–363
   PubMed Web of Science ®Google Scholar
• . Schuckman H, Hazelett S, Powell C, Steer S. A validation of self-reported substance use with biochemical testing among patients presenting to the emergency department seeking treatment for backache, headache, and toothache. Subst Use Misuse. 2008;43(5):589–595
   PubMed Web of Science ®Google Scholar
• . Katz NP, Sherburne S, Beach M,. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003;97(4):1097–1102
   PubMed Web of Science ®Google Scholar
• . Quest Diagnostics. Prescription drug use in America: a report on marijuana and prescription drugs. Madison, NJ: Quest Diagnostics; 2013
   Google Scholar
• . Michna E, Jamison RN, Pham LD,. Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings. Clin J Pain. 2007;23(2):173–179
   PubMed Web of Science ®Google Scholar
• . Dams R, Choo RE, Lambert WE, Jones H, Huestis MA. Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients. Drug Alcohol Depend. 2007;87(2–3):258–267
   PubMed Web of Science ®Google Scholar
• . Heltsley R, Depriest A, Black DL,. Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens. J Anal Toxicol. 2012;36(2):75–80
   PubMedGoogle Scholar
• . Peppin JF, Passik SD, Couto JE,. Recommendations for urine drug monitoring as a component of opioid therapy in the treatment of chronic pain. Pain Med. 2012;13(7):886–896
   PubMed Web of Science ®Google Scholar
• . Fattore L, Fratta W. Beyond THC: the new generation of cannabinoid designer drugs. Front Behav Neurosci. 2011;5:60
   PubMed Web of Science ®Google Scholar
• . Levin FR, Mariani JJ, Brooks DJ, Xie S, Murray KA. Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol. Drug Alcohol Depend. 2010;106(1):65–68
   PubMedGoogle Scholar
• . Kahan M, Wilson L, Mailis-Gagnon A, Srivastava A. Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations. Can Fam Physician. 2011;57(11):1269–1276
   PubMedGoogle Scholar
• . Cone EJ, Fant RV, Rohay JM,. Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases. J Anal Toxicol. 2003;27(2):57–67; discussion 67
   PubMed Web of Science ®Google Scholar
• . Hull MJ, Juhascik M, Mazur F, Flomenbaum MA, Behonick GS. Fatalities associated with fentanyl and co-administered cocaine or opiates. J Forensic Sci. 2007;52(6):1383–1388
   PubMed Web of Science ®Google Scholar
• . Manchikanti L, Damron KS, McManus CD, Barnhill RC. Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: a prospective, observational study. Pain Physician. 2004;7(4):431–437
   PubMedGoogle Scholar
• . Bottcher M, Beck O, Helander A. Evaluation of a new immunoassay for urinary ethyl glucuronide testing. Alcohol Alcohol. 2008;43(1):46–48
   PubMed Web of Science ®Google Scholar
• . Beck O, Stephanson N, Bottcher M, Dahmen N, Fehr C, Helander A. Biomarkers to disclose recent intake of alcohol: potential of 5-hydroxytryptophol glucuronide testing using new direct UPLC-tandem MS and ELISA methods. Alcohol Alcohol. 2007;42(4):321–325
   PubMed Web of Science ®Google Scholar
• . Meghani SH, Wiedemer NL, Becker WC, Gracely EJ, Gallagher RM. Predictors of resolution of aberrant drug behavior in chronic pain patients treated in a structured opioid risk management program. Pain Med. 2009;10(5):858–865
   PubMedGoogle Scholar
• . Wiedemer NL, Harden PS, Arndt IO, Gallagher RM. The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse. Pain Med. 2007;8(7):573–584
   PubMed Web of Science ®Google Scholar
• . Becker WC, Meghani SH, Barth KS, Wiedemer N, Gallagher RM. Characteristics and outcomes of patients discharged from the Opioid Renewal Clinic at the Philadelphia VA Medical Center. Am J Addict. 2009;18(2):135–139
   PubMed Web of Science ®Google Scholar